Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Yuya, Atsuta"'
Autor:
Tatsuya Konishi, Hiroaki Ogawa, Yuho Najima, Shinpei Hashimoto, Satoshi Kito, Yuya Atsuta, Atsushi Wada, Hiroto Adachi, Ryosuke Konuma, Yuya Kishida, Akihito Nagata, Yuta Yamada, Satoshi Kaito, Junichi Mukae, Atsushi Marumo, Yuma Noguchi, Naoki Shingai, Takashi Toya, Aiko Igarashi, Hiroaki Shimizu, Takeshi Kobayashi, Kazuteru Ohashi, Noriko Doki, Keiko Nemoto Murofushi
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 2617-2626 (2022)
Background and objectives Intensity-modulated radiation therapy (IMRT) helps achieve good radiation dose conformity and precise dose evaluation. We conducted a single-centre prospective study to assess the safety and feasibility of total body irradia
Externí odkaz:
https://doaj.org/article/35f0ba96a13a4f0383e8927caa9e76d0
Autor:
Takashi Toya, Daichi Sadato, Takahiro Sanada, Tomoko Honda, Yuya Atsuta, Noritaka Sekiya, Hiroaki Shimizu, Yuho Najima, Takeshi Kobayashi, Yuka Harada, Michinori Kohara, Noriko Doki
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 309-311 (2023)
Externí odkaz:
https://doaj.org/article/fe2de3b972304e2a9c6326b03336bcf4
Autor:
Yuya Kishida, Naoki Shingai, Konan Hara, Makiko Yomota, Chika Kato, Satoshi Sakai, Yasuhiro Kambara, Yuya Atsuta, Ryosuke Konuma, Atsushi Wada, Daisuke Murakami, Shiori Nakashima, Yusuke Uchibori, Daishi Onai, Atsushi Hamamura, Akihiko Nishijima, Takashi Toya, Hiroaki Shimizu, Yuho Najima, Takeshi Kobayashi, Hisashi Sakamaki, Kazuteru Ohashi, Noriko Doki
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Late-onset noninfectious pulmonary complications (LONIPC) are a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). However, the clinical impact of lung function deterioration itself in lon
Externí odkaz:
https://doaj.org/article/473da633bf2c4450a9a30f94b32d6d39
Autor:
Ryohei Yasukuni, Akiko Sunada, Nagisa Fujiwara, Naoto Masuda, Yuya Atsuta, Syuji Fujii, Tomosumi Kamimura
Publikováno v:
Journal of Photopolymer Science & Technology; 2024, Vol. 37 Issue 4, p401-405, 5p
Autor:
Masahiro Sakaguchi, Yuya Atsuta, Noritaka Sekiya, Yuho Najima, Kazuaki Fukushima, Naoki Shingai, Takashi Toya, Takeshi Kobayashi, Kazuteru Ohashi, Noriko Doki
Publikováno v:
Journal of Global Antimicrobial Resistance. 32:187-194
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74daf9bf88578441bcfcf3a43662b48a
https://doi.org/10.1016/j.jgar.2023.02.001
https://doi.org/10.1016/j.jgar.2023.02.001
Autor:
Hiroaki Ogawa, Tatsuya Konishi, Yuho Najima, Satoshi Kito, Shimpei Hashimoto, Chika Kato, Satoshi Sakai, Yasuhiro Kanbara, Yuya Atsuta, Ryosuke Konuma, Atsushi Wada, Daisuke Murakami, Shiori Nakasima, Yusuke Uchibori, Daishi Onai, Atsushi Hamamura, Akihiko Nishijima, Naoki Shingai, Takashi Toya, Hiroaki Shimizu, Takeshi Kobayashi, Kazuteru Ohashi, Noriko Doki, Keiko Nemoto Murofushi
Publikováno v:
Cancer Science. 114:596-605
This prospective phase I trial aimed to determine the recommended dose of 3-day total marrow and lymphoid irradiation (TMLI) for a myeloablative conditioning regimen by increasing the dose per fraction. The primary end-point of this single-institutio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb8e4cab47f78637d191a6838340906e
https://doi.org/10.1111/cas.15611
https://doi.org/10.1111/cas.15611
Autor:
Takashi Toya, Daichi Sadato, Takahiro Sanada, Tomoko Honda, Yuya Atsuta, Noritaka Sekiya, Hiroaki Shimizu, Yuho Najima, Takeshi Kobayashi, Yuka Harada, Michinori Kohara, Noriko Doki
Publikováno v:
eJHaem. 4:309-311
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c717c40fcd4b4330c878ee5e4c5132b
https://doi.org/10.1002/jha2.637
https://doi.org/10.1002/jha2.637
Autor:
Takeshi Kobayashi, Atsushi Wada, Yuma Noguchi, Aiko Igarashi, Tatsuya Konishi, Ryohei Nagata, Shuntaro Ikegawa, Yuta Yamada, Satoshi Kaito, Atsushi Marumo, Hisashi Sakamaki, Yuho Najima, Yuya Kishida, Ryosuke Konuma, Akihito Nagata, Noriko Doki, Kazuteru Ohashi, Kyoko Inamoto, Takashi Toya, Hiroto Adachi, Junichi Mukae, Yuya Atsuta
Publikováno v:
International Journal of Hematology. 115:244-254
Fludarabine with intravenous busulfan (6.4 mg/kg; FB2) and fludarabine with intermediate-dose melphalan (140 mg/m2; FM140) are the most widely used reduced-intensity conditioning (RIC) regimens for allogeneic hematopoietic stem cell transplantation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8860f1bc33494cd17910c19bcf6266b
https://doi.org/10.1007/s12185-021-03233-4
https://doi.org/10.1007/s12185-021-03233-4
Autor:
Yu, Yagi, Yusuke, Kanemasa, Yuki, Sasaki, Yudai, Hayashi, Mano, Mino, Chika, Kato, Satoshi, Sakai, An, Ohigashi, Yasuhiro, Kanbara, Yuka, Morita, Taichi, Tamura, Yuya, Atsuta, Ryosuke, Konuma, Shohei, Nakamura, Atsushi, Wada, Toshihiro, Okuya, Akihiko, Kageyama, Daisuke, Murakami, Shiori, Nakashima, Yusuke, Uchibori, Daishi, Onai, Atsushi, Hamamura, Akihiko, Nishijima, Yasushi, Omuro, Naoki, Shingai, Takuya, Shimizuguchi, Takashi, Toya, Hiroaki, Shimizu, Yuho, Najima, Takeshi, Kobayashi, Kyoko, Haraguchi, Kazuteru, Ohashi, Noriko, Doki, Yoshiki, Okuyama, Tatsu, Shimoyama
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 63(10)
Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the approach to patients with relapsed or refractory diffuse large B-cell lymphoma (r/r DLBCL). This study retrospectively analyzed patients treated with commercially available tisagen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f5315a8e70ea9f1dbec3ded2572a84d0
https://pubmed.ncbi.nlm.nih.gov/36351641
https://pubmed.ncbi.nlm.nih.gov/36351641
Autor:
Takashi Toya, Yuya Atsuta, Takahiro Sanada, Tomoko Honda, Daichi Sadato, Noritaka Sekiya, Hiroko Kogure, Sonomi Takakuwa, Daishi Onai, Naoki Shingai, Hiroaki Shimizu, Yuho Najima, Takeshi Kobayashi, Kazuteru Ohashi, Yuka Harada, Michinori Kohara, Noriko Doki
Publikováno v:
Cancer scienceREFERENCES.
Antibody persistence several months after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccination in allogeneic stem cell transplantation recipients remains largely unknown. We sequentially evaluated the humoral response to two
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9300da0bb3edd0d81aa91988d234fb4b
https://pubmed.ncbi.nlm.nih.gov/36161681
https://pubmed.ncbi.nlm.nih.gov/36161681